For Media Inquiries, Please Contact:
Jordan Berman
Vice President,
Global Corporate Affairs
Apotex Inc.
150
Signet Drive
North York,
ON, M9L 1T9
Canada
416-401-7487
Email
Press Center
-
April 21, 2020
-
April 17, 2020
-
April 13, 2020
-
March 20, 2020
-
February 4, 2020
-
December 5, 2019Canada’s leading generic drug manufacturer, Apotex, announced today that its first shipment of the drug tamoxifen has been released to the Canadian market. Additional releases are scheduled for December 2019 and January 2020.
-
June 1, 2018Health Canada Leads the Way by Approving the First-Ever Pegfilgrastim Biosimilar in any Highly Regulated World Market
-
September 1, 2017
-
February 9, 2017
-
March 31, 2016Apobiologix®, a Division of Apotex Inc., today launched Grastofil®, its first subsequent entry biologic (SEB) approved in Canada.
-
March 24, 2016Apotex Inc. announced today that it has launched the first generic version of Merck's Nasonex® nasal spray (mometasone furoate monohydrate) in the United States.